Mridula Saxena

580 total citations
25 papers, 443 citations indexed

About

Mridula Saxena is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Mridula Saxena has authored 25 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Computational Theory and Mathematics and 11 papers in Organic Chemistry. Recurrent topics in Mridula Saxena's work include Computational Drug Discovery Methods (13 papers), Synthesis and biological activity (6 papers) and Chemical Synthesis and Analysis (3 papers). Mridula Saxena is often cited by papers focused on Computational Drug Discovery Methods (13 papers), Synthesis and biological activity (6 papers) and Chemical Synthesis and Analysis (3 papers). Mridula Saxena collaborates with scholars based in India, United States and United Arab Emirates. Mridula Saxena's co-authors include Anil K. Saxena, Sisir Nandi, Jill A. Nord, Jeffrey P. Nadler, Judith Berger, Philip Prathipati, Anil K. Saxena, Amit K. Gupta, Mohit Kumar and Shiv Kumar Agarwal and has published in prestigious journals such as CHEST Journal, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Mridula Saxena

25 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mridula Saxena India 10 177 119 98 95 93 25 443
S. M. Zahid Hosen Bangladesh 15 283 1.6× 71 0.6× 103 1.1× 56 0.6× 65 0.7× 47 564
Khattab Al-Khafaji Türkiye 15 263 1.5× 125 1.1× 206 2.1× 57 0.6× 116 1.2× 32 648
Francesca Alessandra Ambrosio Italy 15 360 2.0× 120 1.0× 125 1.3× 77 0.8× 175 1.9× 38 697
Matthew L. Danielson United States 7 354 2.0× 135 1.1× 168 1.7× 58 0.6× 49 0.5× 7 737
Nizar A. Al‐Shar’i Jordan 16 331 1.9× 144 1.2× 105 1.1× 51 0.5× 114 1.2× 48 650
Md. Junaid Bangladesh 14 219 1.2× 81 0.7× 96 1.0× 66 0.7× 59 0.6× 30 484
Priyanshu Bhargava Japan 15 270 1.5× 59 0.5× 60 0.6× 60 0.6× 68 0.7× 23 723
Li Xiao United States 18 396 2.2× 68 0.6× 41 0.4× 91 1.0× 162 1.7× 28 761
Ramesh Bambal United States 15 285 1.6× 157 1.3× 48 0.5× 38 0.4× 48 0.5× 30 601
Muhammad Nasir Iqbal Pakistan 11 170 1.0× 74 0.6× 113 1.2× 40 0.4× 35 0.4× 47 475

Countries citing papers authored by Mridula Saxena

Since Specialization
Citations

This map shows the geographic impact of Mridula Saxena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mridula Saxena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mridula Saxena more than expected).

Fields of papers citing papers by Mridula Saxena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mridula Saxena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mridula Saxena. The network helps show where Mridula Saxena may publish in the future.

Co-authorship network of co-authors of Mridula Saxena

This figure shows the co-authorship network connecting the top 25 collaborators of Mridula Saxena. A scholar is included among the top collaborators of Mridula Saxena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mridula Saxena. Mridula Saxena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nandi, Sisir, et al.. (2020). Repurposing of Potent Mtase Inhibitors Against ZIKV Utilizing Structure-Based Molecular Docking. 5(4). 53–68. 3 indexed citations
2.
Nandi, Sisir, Mohit Kumar, Mridula Saxena, & Anil K. Saxena. (2020). The Antiviral and Antimalarial Drug Repurposing in Quest of Chemotherapeutics to Combat COVID-19 Utilizing Structure-Based Molecular Docking. Combinatorial Chemistry & High Throughput Screening. 24(7). 1055–1068. 25 indexed citations
3.
Nandi, Sisir & Mridula Saxena. (2020). Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus. Current Topics in Medicinal Chemistry. 20(29). 2692–2707. 33 indexed citations
4.
Gupta, Amit K., Arun Rawat, Arvind K. Srivastava, et al.. (2019). Synthesis, SAR and docking studies of substituted aryl phenylthiazolyl phenylcarboxamide as potential protein tyrosine phosphatase 1B ( PTP 1B) inhibitors. Chemical Biology & Drug Design. 94(1). 1378–1389. 5 indexed citations
5.
Saxena, Mridula, et al.. (2019). Target Enzyme in Alzheimer’s Disease: Acetylcholinesterase Inhibitors. Current Topics in Medicinal Chemistry. 19(4). 264–275. 130 indexed citations
6.
Kumar, Mohit, et al.. (2019). Control of Aedes aegypti Mosquito Vector by Attempting QSAR Modeling on Phenoxyacetamide-Based Inhibitors to Target AChE1. 8(1). 0–0. 1 indexed citations
7.
Srivastava, Nitin, et al.. (2019). NOVEL SYNTHESIS OF SYMMETRICAL DIALKYL/DIARYLALKYLTRITHIOCARBONATES IN NON-AQUEOUS MEDIUM AT ROOM TEMPERATURE USING CS2, CS2CO3 AND ALKYL/ARYL-ALKYL HALIDES. RASAYAN Journal of Chemistry. 12(1). 333–337. 7 indexed citations
8.
Gupta, Amit K., Ravi Sonkar, Salil Varshney, et al.. (2018). Lipid Lowering Oxopropanylindole Hydrazone Derivatives with Antioxidant and Anti-hyperglycemic Activity. Current Topics in Medicinal Chemistry. 18(26). 2256–2265. 2 indexed citations
9.
Gupta, Amit K., Neetu Singh, Vaibhav Mishra, et al.. (2012). Identification of Novel Amino Acid Derived CCK-2R Antagonists As Potential Antiulcer Agent: Homology Modeling, Design, Synthesis, and Pharmacology. Journal of Chemical Information and Modeling. 53(1). 176–187. 13 indexed citations
10.
Gupta, Amit K., Shruti Saxena, & Mridula Saxena. (2010). Integrated ligand and structure based studies of flavonoids as fatty acid biosynthesis inhibitors of Plasmodium falciparum. Bioorganic & Medicinal Chemistry Letters. 20(16). 4779–4781. 15 indexed citations
11.
12.
Prathipati, Philip, et al.. (2004). CoMFA AND CoMSIA STUDIES ON A SET OF BENZYL PIPERAZINES, PIPERADINES, PYRAZINOPYRIDOINDOLES, PYRAZINOISOQUINOLINES AND SEMI RIGID ANALOGS OF DIPHENHYDRAMINE. Medicinal Chemistry Research. 13(8-9). 746–757. 5 indexed citations
13.
Saxena, Anil K., Siya Ram, Mridula Saxena, et al.. (2003). QSAR studies in substituted 1,2,3,4,6,7,12,12a-octa-hydropyrazino[2′,1′:6,1]pyrido[3,4-b]indoles—a potent class of neuroleptics. Bioorganic & Medicinal Chemistry. 11(9). 2085–2090. 8 indexed citations
14.
Singh, Rajendra Bahadur, et al.. (2000). Fourier transform infrared spectra and normal mode analysis of 1-[(3-methyl phenyl) piperazin-1-yl]-3-[thio(4-acetamido-phenyl]propane: a potent 5-HT2 and D2 receptor ligand. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 56(7). 1267–1275. 4 indexed citations
15.
Saxena, Anil K. & Mridula Saxena. (1995). Developments in anticonvulsants. Birkhäuser Basel eBooks. 44. 185–291. 8 indexed citations
16.
deStevens, George, Paul D. Hoeprich, Richard M. Schultz, et al.. (1995). Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Birkhäuser Basel eBooks. 1 indexed citations
17.
Saxena, Anil K. & Mridula Saxena. (1992). Developments in antihistamines (H1). Birkhäuser Basel eBooks. 39. 35–125. 2 indexed citations
18.
Nadler, Jeffrey P., et al.. (1991). Amoxicillin-Clavulanic Acid for Treating Drug-Resistant Mycobacterium tuberculosis. CHEST Journal. 99(4). 1025–1026. 89 indexed citations
19.
20.
Saxena, Anil K. & Mridula Saxena. (1986). Advances in chemotherapy of malaria. Birkhäuser Basel eBooks. 30. 221–280. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. M. Zahid Hosen Breakdown of academic impact, for papers by Khattab Al-Khafaji Breakdown of academic impact, for papers by Francesca Alessandra Ambrosio Breakdown of academic impact, for papers by Matthew L. Danielson Breakdown of academic impact, for papers by Nizar A. Al‐Shar’i Breakdown of academic impact, for papers by Md. Junaid Breakdown of academic impact, for papers by Priyanshu Bhargava Breakdown of academic impact, for papers by Li Xiao Breakdown of academic impact, for papers by Ramesh Bambal Breakdown of academic impact, for papers by Muhammad Nasir Iqbal
Rankless by CCL
2026